Replies to post #1606 on Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

I was basing it on the total market forecast by SPPI and Ligand. SPPI notes it as a potential $100M market and Ligand as 150M. So something has to give either higher Evomela pricing or market potential. Good point and something to ponder when we see their revenue next week.